Dynamic Susceptibility Contrast-Enhanced Perfusion Magnetic Resonance (MR) Imaging Combined with Contrast-Enhanced MR Imaging in the Follow-up of Immunogene-Treated Glioblastoma Multiforme

References

• Aronen H. J., Gazit I. E., Louis D. N., Buchbinder B. R., Pardo F. S., Weisskoff R. M., et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994; 191: 41–51
   PubMed Web of Science ®Google Scholar
• Behin A., Hoang-Xuan K., Carpentier A. F., Delattre J. Y. Primary brain tumours in adults. Lancet 2003; 361: 323–31
   PubMed Web of Science ®Google Scholar
• Cha S., Knopp E. A., Johnson G., Litt A., Glass J., Gruber M. L., et al. Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin. Am J Neuroradiol 2000; 21: 881–90
   PubMed Web of Science ®Google Scholar
• Cha S., Knopp E. A., Johnson G., Wetzel S. G., Litt A. W., Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002; 223: 11–29
   PubMed Web of Science ®Google Scholar
• Floeth F. W., Aulich A., Langen K. J., Burger K. J., Bock W. J., Weber F. MR imaging and single-photon emission CT findings after gene therapy for human glioblastoma. Am J Neuroradiol 2001; 22: 1517–27
   PubMed Web of Science ®Google Scholar
• Haselhorst R., Kappos L., Bilecen D., Scheffler K., Mori D., Radu E. W., et al. Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: application of an extended blood-brain barrier leakage correction. J Magn Reson Imaging 2000; 11: 495–505
   PubMed Web of Science ®Google Scholar
• Henry R. G., Vigneron D. B., Fischbein N. J., Grant P. E., Day M. R., Noworolski S. M., et al. Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. Am J Neuroradiol 2000; 21: 357–66
   Google Scholar
• Knopp E. A., Cha S., Johnson G., Mazumdar A., Golfinos J. G., Zagzag D., et al. Glial neoplasms: dynamic contrast-enhanced T2-weighted MR imaging. Radiology 1999; 211: 791–8
   PubMedGoogle Scholar
• Kremer S., Grand S., Berger F., Hoffmann D., Pasquier B., Remy C., et al. Dynamic contrast-enhanced MRI: differentiating melanoma and renal carcinoma metastases from high-grade astrocytomas and other metastases. Neuroradiology 2003; 45: 44–9
   Google Scholar
• Kumar A. J., Leeds N. E., Fuller G. N., Van Tassel P., Maor M. H., Sawaya R. E., et al. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 2000; 217: 377–84
   PubMed Web of Science ®Google Scholar
• Lantos P. L., Louis D. N., Rosenblum M. K., Kleihues P. Tumours of the nervous system. Greenfield´s neuropathology, D. I Graham, P. L Lantos. Arnold, London 2002; 767–1052, 7th ed
   Google Scholar
• Law M., Yang S., Babb J. S., Knopp E. A., Golfinos J. G., Zagzag D., et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. Am J Neuroradiol 2004; 25: 746–55
   PubMedGoogle Scholar
• Moonis G., Liu J., Udupa J. K., Hackney D. B. Estimation of tumor volume with fuzzy-connectedness segmentation of MR images. Am J Neuroradiol 2002; 23: 356–63
   Google Scholar
• Persson A., Skagerberg G., Salford L. G., Englund E. Immunotreatment in patients with glioblastoma multiforme—a histopathological evaluation of reactive and inflammatory changes. Clin Neuropathol 2005; 24: 201–8
   Google Scholar
• Rabinov J. D., Lee P. L., Barker F. G., Louis D. N., Harsh G. R., Cosgrove G. R., et al. In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience. Radiology 2002; 225: 871–9
   PubMed Web of Science ®Google Scholar
• Rosen B. R., Belliveau J. W., Vevea J. M., Brady T. J. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990; 14: 249–65
   PubMed Web of Science ®Google Scholar
• Rosenthal M. A., Ashley D. L., Cher L. Temozolomide-induced flare in high-grade gliomas: a new clinical entity. Intern Med J 2002; 32: 346–8
   Google Scholar
• Salford L. G., Siesjö P., Skagerberg G., Persson B. R. R., Larsson E.-M., Lindvall M., . Search for effective therapy against glioblastoma multiforme – clinical immunisation with autologous glioma cells transduced with the human interferon-gamma gene. Developments in neuroscience. Proceedings of the 2nd International Mt Bandai Symposium for Neuroscience, K Watanabe, et al. Elsevier, Bandai 2001
   Google Scholar
• Schmainda K. M., Rand S. D., Joseph A. M., Lund R., Ward B. D., Pathak A. P., et al. Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. Am J Neuroradiol 2004; 25: 1524–32
   Google Scholar
• Smith M. M., Thompson J. E., Castillo M., Cush S., Mukherji S. K., Miller C. H., et al. MR of recurrent high-grade astrocytomas after intralesional immunotherapy. Am J Neuroradiol 1996; 17: 1065–71
   Google Scholar
• Sugahara T., Korogi Y., Kochi M., Ikushima I., Hirai T., Okuda T., et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. Am J Roentgenol 1998; 171: 1479–86
   PubMedGoogle Scholar
• Weisskoff R. M., Boxerman J. L., Sorensen A. G., Kulke S. M., Campbell T. A., Rosen B. R. Simultaneous blood volume and permeability mapping using single Gd-based contrast injection. Proc. 2nd Society of Magnetic Resonance, San Fransisco 1996; 279
   Google Scholar
• Wetzel S. G., Cha S., Johnson G., Lee P., Law M., Kasow D. L., et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 2002; 224: 797–803
   PubMed Web of Science ®Google Scholar
• Wetzel S. G., Cha S., Law M., Johnson G., Golfinos J., Lee P., et al. Preoperative assessment of intracranial tumors with perfusion MR and a volumetric interpolated examination: a comparative study with DSA. Am J Neuroradiol 2002; 23: 1767–74
   Google Scholar
• Visse E., Siesjo P., Widegren B., Sjogren H. O. Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-gamma, interleukin-7, or B7-1-transfected tumor cells. Cancer Gene Ther 1999; 6: 37–44
   PubMed Web of Science ®Google Scholar
• Vos M. J., Uitdehaag B. M., Barkhof F., Heimans J. J., Baayen H. C., Boogerd W., et al. Interobserver variability in the radiological assessment of response to chemotherapy in glioma. Neurology 2003; 60: 826–30
   PubMed Web of Science ®Google Scholar